News

Dr Mullis is currently a distinguished researcher at Children’s Hospital and Research Institute in Oakland, California. Dr Mullis has received a Nobel Prize in chemistry in 1993 for

Net proceeds are expected to be up to approximately $4.1 million after offering-related fees and expenses. Columbia intends to use the net proceeds from the offering for general

Research will continue via funding from the US government but operations in Proteome Systems’s (PXL) Boston office will be closed within the next three months. PXL will retain

According to the company, the Atlas-based autosegmentation (ABAS) is a software application that produces an estimate of the anatomy boundary contours needed to create a radiation treatment plan.

The test is marketed and sold by Qiagen. The new test is CE marked in Europe for in vitro diagnostic use and available for research use in other

The pivotal Azeptic trial is a randomized study evaluating the efficacy and safety of Zuragen injection in significantly reducing the incidence of catheter-related bloodstream infection in patients requiring

The patent describes and protects a muco-adhesive tablet for various applications in the field of opportunistic infections associated with AIDS and cancer. It has been validated in the

According to the company, Nplate, the first FDA-approved peptibody protein, works by raising and sustaining platelet counts, representing a novel approach for the long-term treatment of this chronic

Tests performed in the laboratories of AMP members have had a significant impact on the understanding and treatment of chronic conditions such as HIV, cancer, heart disease, diabetes,